CUSIP: G6333L101
Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / Stock
-
Total 13F shares
-
11,509,393
-
Share change
-
+3,841,355
-
Total reported value
-
$25,951,620
-
Price per share
-
$2.31
-
Number of holders
-
38
-
Value change
-
+$11,192,929
-
Number of buys
-
18
-
Number of sells
-
25
Quarterly Holders Quick Answers
What is CUSIP G6333L101?
CUSIP G6333L101 identifies ITRM - ITERUM THERAPEUTICS PLC SHS NEW - Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q3 2021
-
Previous quarter:
Q1 2021
Recent filing periods for CUSIP G6333L101:
Institutional Holders of ITERUM THERAPEUTICS PLC SHS NEW - Stock (ITRM) as of Q2 2021
As of 30 Jun 2021,
ITERUM THERAPEUTICS PLC SHS NEW - Stock (ITRM) was held by
38 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
11,509,393 shares.
The largest 10 holders included
RENAISSANCE TECHNOLOGIES LLC, MILLENNIUM MANAGEMENT LLC, Canaan Partners X LLC, New Leaf Venture Partners, L.L.C., TWO SIGMA INVESTMENTS, LP, QS Investors, LLC, FineMark National Bank & Trust, GRIMES & COMPANY, INC., Tower Research Capital LLC (TRC), and Verition Fund Management LLC.
This page lists
38
institutional shareholders reporting positions in this security
for the Q2 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.